Position in MGNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,911,018
+$1,852,174 QoQ
Shares Held
1,062,991
+0.4% QoQ
Ownership
1.67%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 122 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,139,216,221 across 216 Biotechnology names. MGNX ranks #97 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in MGNX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,911,018 | 1,062,991 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,058,844 | 1,058,424 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,218,201 | 756,647 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $373,296 | 222,200 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $121,618 | 100,511 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $36,449 | 28,700 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $391,605 | 119,029 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $484,755 | 114,060 | Shares | Defined | 2024-08-14 | |
| 2023-06-30 | $485,368 | 90,723 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,086,649 | 151,555 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,314,250 | 493,927 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,008,713 | 580,553 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,494,676 | 845,653 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,119,668 | 240,598 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $953,289 | 59,395 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,648,229 | 78,712 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,428,517 | 127,644 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $11,542,981 | 362,417 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $12,970,855 | 567,404 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $18,375,198 | 729,464 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $23,861,883 | 854,652 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,388,248 | 410,352 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||